D
Olema Pharmaceuticals, Inc. OLMA
$5.59 -$0.17-2.95% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 17.08M 17.53M 17.74M 18.82M 18.31M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 147.13M 142.79M 137.26M 133.71M 119.43M
Operating Income -147.13M -142.79M -137.26M -133.71M -119.43M
Income Before Tax -142.30M -128.89M -129.47M -122.68M -109.63M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -142.30 -128.89 -129.47 -122.68 -109.63
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -142.30M -128.89M -129.47M -122.68M -109.63M
EBIT -147.13M -142.79M -137.26M -133.71M -119.43M
EBITDA -146.66M -142.36M -136.87M -133.34M -119.07M
EPS Basic -1.98 -2.01 -2.21 -2.19 -2.06
Normalized Basic EPS -1.17 -1.26 -1.33 -1.34 -1.27
EPS Diluted -1.98 -2.01 -2.21 -2.19 -2.06
Normalized Diluted EPS -1.17 -1.26 -1.33 -1.34 -1.27
Average Basic Shares Outstanding 293.98M 264.76M 234.91M 223.90M 211.62M
Average Diluted Shares Outstanding 293.98M 264.76M 234.91M 223.90M 211.62M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --